Plain-English translation of NCT07279571 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing an AI chatbot — a computer program you can chat with — designed to answer questions about HPV vaccines for patients with gynecologic cancer. The research team wants to know if the chatbot helps patients feel confident about vaccines and whether it increases how many patients decide to get vaccinated.
Many patients with gynecologic cancer have questions about HPV vaccines but may not have easy access to clear, personalized information. This study is exploring whether an AI chatbot can be a helpful tool to answer these questions and support patients in making informed decisions about their health.
You likely qualify if…
You likely don't qualify if…
You would interact with an AI chatbot that answers questions about HPV vaccines, then complete a brief survey about your experience. The survey asks about where you normally get health information, what you thought of the chatbot, and whether it helped you understand vaccines better. The entire process takes place at your clinic visit and should take less than an hour.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States
Collaborators
National Cancer Institute (NCI)
Enrollment target
~48 participants
Started
June 2026
Primary completion
June 2027
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in June 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.